Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
16.57
-0.20 (-1.19%)
Sep 10, 2026, 1:00 PM HKT

HKG:6826 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,3212,4462,6802,6352,1031,750
Revenue Growth
-10.28%-8.71%1.70%25.27%20.19%32.14%
Gross Profit
1,5461,6901,8371,8471,4471,260
Operating Income
124.51239.23372.03391.79164.38196.9
Net Income
152.57251.01420.45416.12180.47352.23
Earnings Per Share
0.661.081.801.750.531.02
EPS Growth
-61.26%-39.96%2.86%230.53%-48.01%54.06%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Mainland China
2,0372,2462,1821,6991,543
Europe
155.1154.22136.05140.8166.97
United States of America (USA)
112.46137.78120.28103.7282.92
Other Regions and Countries
141.96141.79196.77159.8357.64
Total
2,4462,6802,6352,1031,750

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,4022,5772,7542,7752,5552,919
Total Debt
443.22398.5448.43407.95118.26105.51
Net Cash (Debt)
1,9592,1782,3062,3672,4372,814
Net Cash Growth
-16.06%-5.53%-2.57%-2.88%-13.40%-6.34%
Net Cash Per Share
8.499.409.899.977.168.15

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
316490.97648.57634.45231.3342.29
Capital Expenditures
-233.47-184.19-362.18-265.6-309.21-270.88
Free Cash Flow
82.53306.78286.39368.85-77.9171.41
Free Cash Flow Growth
-79.13%7.12%-22.36%---1.34%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.61%69.06%68.54%70.09%68.79%71.98%
Operating Margin
5.36%9.78%13.88%14.87%7.81%11.25%
Pretax Margin
5.87%9.78%17.40%19.29%11.21%21.86%
Profit Margin
6.57%10.26%15.69%15.79%8.58%20.13%
FCF Margin
3.56%12.54%10.69%14.00%-3.70%4.08%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.1671.0001.0000.5100.2860.500
Dividend Per Share Growth
-10.63%0%96.00%78.58%-42.86%40.02%
Dividend Yield
6.96%4.82%4.40%2.24%1.43%1.99%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
21.9736.4029.8338.3880.5253.77
Forward PE
-9.5110.7312.5412.8513.24
P/FCF Ratio
76.3629.7943.7943.30-265.24
PS Ratio
2.713.744.686.066.9110.82